Carbon fibre nanotube X-ray machine manufacturer Micro-X has taken back a measure of control over the distribution of its Nano portable X-ray machine.
Until now the Nano has been distributed and branded exclusively by global group Carestream Health Inc as the Carestream DRX Revolution Nano.
Such exclusive distribution arrangements are often used by start-up technology businesses that do not have global sales and marketing capabilities, but they can result in sub-optimal sales.
Micro-X and Carestream have now amended the distribution agreement and the arrangements will no longer be exclusive, allowing Micro-X to market the Nano in its own right.
Micro-X managing director Peter Rowland (pictured) said there had been a surge in Nano orders with the Covid-19 pandemic, as the Nano is used for diagnosis of the progression of the disease.
Rowland said: “Over the past 12 months, Micro-X has really transformed itself and strengthened its sales, marketing and production capabilities.
“This change…will give the Micro-X the opportunity to open up new sales channels and imaging partnerships and the potential for additional volumes in production to help our price competitiveness.”
Micro-X took the step following the success of its direct marketing strategy for the ruggedised military version of the Nano, branded as the Rover.
In October the World Health Organisation bought $.4 million worth of Rovers for delivery to Pacific Island nations, as part of the global fight against the Covid-19 virus.
the Nano and Rover are based on the world’s only nanotube X-ray emitter, marking a step-change in a technology around for more than a century.
Picture: Micro-X/Peter Rowland
Subscribe to our free @AuManufacturing newsletter here.